Literature DB >> 2202342

Primary irradiation, surgery or combined therapy in squamous cell carcinoma of the larynx. A comparison of treatment results from two centers.

H Vermund1, M Boysen, J H Brandenburg, J Evensen, A B Jacobsen, O Kaalhus, J Tausjø, E Thorud, A L Wiley, F Winther.   

Abstract

We compared two groups of patients with squamous cell carcinoma of the larynx. Group 1 consisted of 483 patients treated from 1958 through 1978. Primary surgery was selected in 41% pre- or postoperative radiation therapy in 16% and primary radiation therapy in 43%. Group 2 consisted of 247 patients treated from 1978 through 1983. Primary surgery was selected in only 1.6%, pre- or postoperative radiation therapy in 23%, and primary radiation therapy, with surgery in reserve for residual or recurrent carcinoma, in 76%. Although the results were comparable for patients with early stage tumors in the two groups, significantly higher local-regional tumor control rates and corrected survival rates were recorded for patients with advanced tumors in group 2. More patients survived with a cancer-free functional larynx, the surgical salvage rates were higher, the complication rates and the death rates lower in group 2 compared to group 1.

Entities:  

Mesh:

Year:  1990        PMID: 2202342     DOI: 10.3109/02841869009090038

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  5 in total

1.  Radiotherapy or CO(2) laser surgery as treatment of T(1a) glottic carcinoma?

Authors:  Vera Mahler; Morten Boysen; Kjell Brøndbo
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-11-08       Impact factor: 2.503

2.  Long-term trends in gender, T-stage, subsite and treatment for laryngeal cancer at a single center.

Authors:  Jesper Brandstorp-Boesen; Ragnhild Sørum Falk; Morten Boysen; Kjell Brøndbo
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-05-29       Impact factor: 2.503

3.  Histological grading in the deep invasive front of T1 and T2 glottic squamous cell carcinomas has high prognostic value.

Authors:  M Bryne; N Jenssen; M Boysen
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

4.  Treatment of upper aerodigestive tract cancers in England and its effect on survival.

Authors:  D M Edwards; N W Johnson
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

5.  Bax expression has prognostic significance that is enhanced when combined with AgNOR counts in glottic carcinomas.

Authors:  X Xie; O P Clausen; P De Angelis; M Boysen
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.